Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
p acnes corneal ulcer endopthalmitis kaposi esotropia intraocular uveitis optic neuritis anisocoria retinitisYour Article Summary
See Latest ArticlesUltimate Fate of Oncology Drugs Approved by the US Food and Drug Administration Without a Randomized Trial
Journal of Clinical Oncology, 10/16/09
Tsimberidou A–M et al. – Nonrandomized clinical trials with definitive end points can yield US Food and Drug Administration approvals, and these drugs have a reassuring record of long–term safety and efficacy.
Related Articles
Screening the Drug Sensitivity Genes Related to GEM and CDDP in the Lung Cancer Cell-lines
Chinese Journal of Lung Cancer, 10/20/09
Relevance Score: 67%
Medulloblastoma in childhood: revisiting intrathecal therapy in infants and children
Cancer Chemotherapy and Pharmacology, 10/29/09
Relevance Score: 66%
Medtronic Launches New Neuro Oncology Surgical Imaging System Internationally
Medtronic, 10/28/09
Relevance Score: 66%
Global drug development in cancer: a cross-sectional study of clinical trial registries
Annals of Oncology, 10/20/09
Relevance Score: 66%
Improving pharmaceutical care in oncology by pharmacoinformatics: the evolving role of informatics and the internet for drug therapy
The Lancet Oncology, 10/01/09
Relevance Score: 66%
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer
Journal of Hematology & Oncology, 03/14/10
Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer
BMC Cancer, 03/12/10
Today in Chemotherapy/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron Depot for the Palliative Treatment of Advanced Prostate Cancer
Abbott, 03/12/10
Effects on the visual system might contribute to some of the cognitive deficits of cancer chemotherapy-induced chemo-fog
Journal of Clinical Pharmacy and Therapeutics, 03/11/10
Biomarkers of chemotherapy resistance in breast cancer identified by proteomics: Current status
Cancer Letters, 03/10/10
Today in Drug Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Approves Boston Scientifics Express LD Iliac Stent System
Boston Scientific, 03/12/10
Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron Depot for the Palliative Treatment of Advanced Prostate Cancer
Abbott, 03/12/10
U.S. FDA and Health Canada Approve Use of Molybdenum 99 From Maria Reactor
Covidien, 03/12/10
Article Search
Sponsor